Aledade has raised $545.0M in total across 7 funding rounds.
Aledade's investors include Alkeon Capital, BoxOne Ventures, Buckley Ventures, Matt Ocko, Dragoneer Investment Group, Earl Grey Capital, Endeavor Venture Funds, FirstHand Alliance, Goat Capital, Greylock, GSV Ventures, IVP.
Aledade is a Bethesda, Maryland-based healthcare technology company founded in 2014 that empowers independent primary care practices, community health centers, and clinics to succeed in value-based care through its network of Accountable Care Organizations (ACOs).[1][2][3][4][6] It provides data insights, workflow tools, coaching, policy expertise, payer relationships, and integrations with over 100 EHRs and 300+ external data sources to help clinicians manage patient outcomes, reduce costs, and generate shared savings—serving over 20,000 clinicians across 46 states and D.C., with 2.8 million lives under management.[2][5][6] In 2023, 93% of its ACO partners earned shared savings (vs. the national 70% average), and it has created over $800 million in system-wide savings since inception, including partnerships like a 10-year deal with Humana for Medicare Advantage primary care.[2][4][6]
Aledade's growth momentum is strong: recognized by Newsweek as a top World's Best Digital Health Company in 2024 for medical management, ranked No. 3 by Forbes among U.S. healthcare startups, and employing over 2,000 professionals while expanding to manage 2.5-2.8 million patient lives through 1,900+ partnerships and 200+ value-based contracts.[2][3][6][7] Five of the top 10 Medicare Shared Savings Program ACOs are Aledade affiliates, underscoring its scale in transforming primary care economics.[2]
Aledade was founded in 2014 by Farzad Mostashari, M.D., former head of the Office of the National Coordinator for Health Information Technology at the U.S. Department of Health and Human Services (HHS), who recognized that small, independent primary care physicians (PCPs) were ideally positioned to thrive under emerging value-based care policies but lacked the tools and support.[4] Drawing from his HHS experience directing IT infrastructure to cut costs and boost outcomes, Mostashari launched Aledade with seed funding from Venrock to help PCPs form ACOs, providing data analytics, technology, regulatory know-how, payer ties, and hands-on guidance while sharing savings.[1][4]
Early traction built quickly: by 2022, its 1,100+ practices across 37 states served 1.7 million patients and generated $800 million in savings over seven years; pivotal moments include scaling to 1,900+ partners by 2024, launching the Humana partnership in 2023, and earning top industry accolades, humanizing its mission through physician-led success stories like those from Dr. Christine Meyer and rural clinics.[2][4][6]
Aledade stands out in value-based primary care enablement through:
Aledade rides the shift from fee-for-service to value-based care, a U.S. healthcare trend accelerated by Medicare policies, rising costs (projected $6.8T in 2030), and demands for outcomes over volume.[1][4] Its timing aligns perfectly with post-ACA expansions like MSSP and Medicare Advantage growth, where independents (80% of U.S. primary care) struggle against consolidated systems—market forces like payer incentives and data interoperability (via HHS roots) favor its model.[2][4][6]
By enabling 2.8M lives and $800M+ savings, Aledade influences the ecosystem: it democratizes ACO participation for small practices, boosts digital health adoption (e.g., EHR integrations), and sets benchmarks—rivals like Pearl Health or DataLink focus narrower, but Aledade's scale (46 states) accelerates primary care's role in bending cost curves and improving public health.[1][2]
Aledade is poised for continued dominance, expanding its 2.8M lives and 200+ contracts amid Medicare Advantage surges and AI-driven care tools, potentially hitting 4M+ patients by 2027 via new payer deals and CKD/advance care modules.[2][5][6] Trends like regulatory pushes for interoperability, chronic disease focus, and rural health equity will propel it, evolving influence from enabler to ecosystem shaper—perhaps acquiring tech like Abridge for AI summaries.
This positions Aledade as the go-to for independent primary care's value-based future, fulfilling Mostashari's vision of better health, care, and costs.[2][4]
Aledade has raised $545.0M across 7 funding rounds. Most recently, it raised $260.0M Series F in June 2023.
